The road to wellness: The task of getting lifesaving medical isotopes to patients

February 2, 2024, 3:01PMNuclear NewsTim Gregoire
A vial of Ac-225 produced by Niowave stands next to its lead shipping pig. (Photo: Niowave)

According to the Council on Radionuclides and Radiopharmaceuticals, more than 82,000 nuclear imaging procedures using nuclear medicine are performed throughout the world every day. To administer these vital medical procedures, radiopharmaceutical companies and hospitals rely on a handful of producers of medical radioisotopes.

NorthStar completes construction of Mo-99 production facility

December 6, 2022, 7:01AMNuclear News
The electron accelerator that will be used for Mo-99 production at NorthStar’s newly completed facility in Wisconsin. (Photo: NNSA)

NorthStar Medical Radioisotopes has completed construction and all equipment installation at its new facility in Beloit, Wis., to produce the medical radioisotope molybdenum-99 without the use of high-enriched uranium, the Department of Energy’s National Nuclear Security Administration announced last week.

NNSA issues Mo-99 cooperative agreement to Niowave

December 6, 2021, 3:00PMNuclear News

The Department of Energy’s National Nuclear Security Administration has issued a cooperative agreement worth $13 million to Niowave, of Lansing, Mich., to support the commercial production of molybdenum-99, a critical isotope used in more than 40,000 medical procedures in the United States each day, including the diagnosis of heart disease and cancer.